Product Information
AMLODIPINE-OLMESARTAN 10-20 MG is a generic product labeled by Camber Pharmaceuticals Inc., priced at $0.2626 per EA under NDC 31722044790. Its NADAC has been published 25 times since Jan 7, 2026.
The Low Outlier badge above means this manufacturer's average price in the Amlodipine and Olmesartan Medoxomil market falls below Q1 − 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
10; 20 mg/1; mg/1
Manufacturer
Camber Pharmaceuticals Inc.NDC
31722044790
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMILApproval Type
Generic (ANDA)
FDA Application
ANDA209591On Market Since
2/14/2025
Pharmacological Classes
Price Statistics
The NADAC for AMLODIPINE-OLMESARTAN 10-20 MG has been published 25 times since Jan 7, 2026, and over the history we have for it it has declined 18.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2626 per EA |
|---|---|
| All-time high | $0.3303 (Feb 11, 2026) |
| All-time low | $0.2626 (Jun 17, 2026) |
| 52-week high | $0.3303 |
| 52-week low | $0.2626 |
| Median price | $0.3043 |
| Average price | $0.3040 |
| Largest weekly change | -11.1% (Jun 17, 2026) |
| Weeks tracked | 25 |
| Tracking since | Jan 7, 2026 |
Generic Alternatives
The matcher finds 5 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 5 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of AMLODIPINE-OLMESARTAN 10-20 MG?
The current National Average Drug Acquisition Cost (NADAC) for AMLODIPINE-OLMESARTAN 10-20 MG, manufactured by Camber Pharmaceuticals Inc., is $0.2626 per EA (NDC 31722044790), effective Jun 24, 2026.
How has the price of AMLODIPINE-OLMESARTAN 10-20 MG changed over time?
Over the history we have for it, the NADAC for AMLODIPINE-OLMESARTAN 10-20 MG has declined 18.2%. It has been tracked across 25 weekly CMS publications since Jan 7, 2026.
What are the highest and lowest recorded NADAC prices for AMLODIPINE-OLMESARTAN 10-20 MG?
Since Jan 7, 2026, the NADAC for AMLODIPINE-OLMESARTAN 10-20 MG has ranged from a low of $0.2626 (Jun 17, 2026) to a high of $0.3303 (Feb 11, 2026), with a median of $0.3043 per EA.
Are there cheaper alternatives to AMLODIPINE-OLMESARTAN 10-20 MG?
5 NADAC-published products share the same active ingredient, strength, and dosage form as AMLODIPINE-OLMESARTAN 10-20 MG, but none are currently priced below it.
Who manufactures AMLODIPINE-OLMESARTAN 10-20 MG?
AMLODIPINE-OLMESARTAN 10-20 MG (NDC 31722044790) is labeled by Camber Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification